Part 8/10:
The discussion extends into the ethics of prescribing and distributing powerful drugs like Ozempic. Some doctors are alleged to prioritize profit, stockpiling medication for wealthy clients, including celebrities, sometimes at the expense of their typical diabetic patients, who depend on these drugs for their health. This creates a dangerous environment where the medication's shortages threaten lives.
Medical professionals who publicly endorse or dismiss concerns about Ozempic may be influenced by financial incentives or industry pressures, undermining their oath to "do no harm." The debate reflects a broader issue of trust in medical advice and the pharmaceutical industry's influence.